Produkty 571-35-7

CAS 571-35-7 występuje w naszej ofercie pod nazwami: (3Beta,13Alpha)-3-Hydroxyandrost-5-en-17-one, (3b,13a)-3-Hydroxyandrost-5-en-17-one. Oferty producentów: TRC. Dostępne opakowania: 1g, 2,5g, 500mg.

(3Beta,13Alpha)-3-Hydroxyandrost-5-en-17-one
TRC
  • opakowanie: 1g, 500mg
  • Warianty: 2
Zobacz produkt
(3b,13a)-3-Hydroxyandrost-5-en-17-one
TRC
  • opakowanie: 2,5g
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,8R,9S,10R,13R,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one (CAS 571-35-7) to związek chemiczny o wzorze sumarycznym C19H28O2 i masie molowej 288.4 g/mol. Nazwa systematyczna IUPAC: (3S,8R,9S,10R,13R,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one. InChIKey: FMGSKLZLMKYGDP-JLZSVDHQSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H28O2
Masa molowa288.4 g/mol
Nazwa IUPAC(3S,8R,9S,10R,13R,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
InChIKeyFMGSKLZLMKYGDP-JLZSVDHQSA-N
SMILESC[C@@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 3beta-hydroxy-13alpha-androst-5-en-17-one, (3b,13a)-3-Hydroxyandrost-5-en-17-one
Powiązane formy tego związku
(3R,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3S,8R,9S,10R,13S,14S)-2,2,3,4,4-pentadeuterio-3-hydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-one C19H28O2
(3S,8R,9S,10R,13S,14S)-2,2,3,4,4,6-hexadeuterio-3-hydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-one C19H28O2
3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
Izomery (ten sam wzór sumaryczny)
(3S,5S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H28O2
(4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenoic acid C19H28O2
(3R,5R,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3R,5S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(8R,9S,10R,13S,14S,17S)-13-ethyl-17-hydroxy-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one C19H28O2
(3S,5R,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2